 | • レポートコード：B-GIR08C2140 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、エトドラクの世界市場について調べ、まとめました。種類別セグメントは、錠剤、カプセル等、用途別セグメントは、関節リウマチ、変形性関節症、軽度から中等度の痛み、その他等に区分しました。エトドラクの世界市場概観、企業動向、企業別エトドラクシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・エトドラクの市場概観 ・エトドラクの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・エトドラクの企業別販売動向、市場シェア、市場集中度、競争動向 ・エトドラクの世界市場規模 ・エトドラクの北米市場分析（アメリカ、カナダ、メキシコ等） ・エトドラクのアメリカ市場規模推移 ・エトドラクのカナダ市場規模推移 ・エトドラクのメキシコ市場規模推移 ・エトドラクのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・エトドラクのドイツ市場規模推移 ・エトドラクのイギリス市場規模推移 ・エトドラクのロシア市場規模推移 ・エトドラクのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・エトドラクの日本市場規模推移 ・エトドラクの中国市場規模推移 ・エトドラクの韓国市場規模推移 ・エトドラクのインド市場規模推移 ・エトドラクの東南アジア市場規模推移 ・エトドラクの南米市場分析（ブラジル、アルゼンチン等） ・エトドラクの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・エトドラクの種類別分析/販売量、売上、市場シェア（錠剤、カプセル） ・エトドラクの用途別分析/市場規模（関節リウマチ、変形性関節症、軽度から中等度の痛み、その他） ・エトドラクの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・エトドラクの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Etodolac is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Etodolac in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Amneal Pharmaceuticals
Genpharm Ulc
Physicians Total Care
Actavis Elizabeth
Blenheim Pharmacal
Teva
Taro Pharmaceuticals
Apotex
PD-Rx Pharmaceuticals
Nucare Pharmaceuticals
Eon Labs
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tablets
Capsules
Market Segment by Applications, can be divided into
Rheumatoid Arthritis
Osteoarthritis
Mild to Moderate Pain
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Etodolac product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Etodolac, with price, sales, revenue and global market share of Etodolac in 2017 and 2018.
Chapter 3, the Etodolac competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Etodolac breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Etodolac market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Etodolac sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Etodolac Introduction
1.2 Market Analysis by Type
1.2.1 Tablets
1.2.2 Capsules
1.3 Market Analysis by Applications
1.3.1 Rheumatoid Arthritis
1.3.2 Osteoarthritis
1.3.3 Mild to Moderate Pain
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amneal Pharmaceuticals
2.1.1 Business Overview
2.1.2 Etodolac Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amneal Pharmaceuticals Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Genpharm Ulc
2.2.1 Business Overview
2.2.2 Etodolac Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Genpharm Ulc Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Physicians Total Care
2.3.1 Business Overview
2.3.2 Etodolac Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Physicians Total Care Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Actavis Elizabeth
2.4.1 Business Overview
2.4.2 Etodolac Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Actavis Elizabeth Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Blenheim Pharmacal
2.5.1 Business Overview
2.5.2 Etodolac Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Blenheim Pharmacal Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Teva
2.6.1 Business Overview
2.6.2 Etodolac Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Teva Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Taro Pharmaceuticals
2.7.1 Business Overview
2.7.2 Etodolac Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Taro Pharmaceuticals Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Apotex
2.8.1 Business Overview
2.8.2 Etodolac Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Apotex Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 PD-Rx Pharmaceuticals
2.9.1 Business Overview
2.9.2 Etodolac Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 PD-Rx Pharmaceuticals Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Nucare Pharmaceuticals
2.10.1 Business Overview
2.10.2 Etodolac Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Nucare Pharmaceuticals Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Eon Labs
2.11.1 Business Overview
2.11.2 Etodolac Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Eon Labs Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Etodolac Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Etodolac Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Etodolac Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Etodolac Manufacturer Market Share in 2018
3.3.2 Top 6 Etodolac Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Etodolac Market Analysis by Regions
4.1 Global Etodolac Sales, Revenue and Market Share by Regions
4.1.1 Global Etodolac Sales and Market Share by Regions (2014-2019)
4.1.2 Global Etodolac Revenue and Market Share by Regions (2014-2019)
4.2 North America Etodolac Sales and Growth Rate (2014-2019)
4.3 Europe Etodolac Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Etodolac Sales and Growth Rate (2014-2019)
4.5 South America Etodolac Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Etodolac Sales and Growth Rate (2014-2019)
5 North America Etodolac by Country
5.1 North America Etodolac Sales, Revenue and Market Share by Country
5.1.1 North America Etodolac Sales and Market Share by Country (2014-2019)
5.1.2 North America Etodolac Revenue and Market Share by Country (2014-2019)
5.2 United States Etodolac Sales and Growth Rate (2014-2019)
5.3 Canada Etodolac Sales and Growth Rate (2014-2019)
5.4 Mexico Etodolac Sales and Growth Rate (2014-2019)
6 Europe Etodolac by Country
6.1 Europe Etodolac Sales, Revenue and Market Share by Country
6.1.1 Europe Etodolac Sales and Market Share by Country (2014-2019)
6.1.2 Europe Etodolac Revenue and Market Share by Country (2014-2019)
6.2 Germany Etodolac Sales and Growth Rate (2014-2019)
6.3 UK Etodolac Sales and Growth Rate (2014-2019)
6.4 France Etodolac Sales and Growth Rate (2014-2019)
6.5 Russia Etodolac Sales and Growth Rate (2014-2019)
6.6 Italy Etodolac Sales and Growth Rate (2014-2019)
7 Asia-Pacific Etodolac by Country
7.1 Asia-Pacific Etodolac Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Etodolac Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Etodolac Revenue and Market Share by Country (2014-2019)
7.2 China Etodolac Sales and Growth Rate (2014-2019)
7.3 Japan Etodolac Sales and Growth Rate (2014-2019)
7.4 Korea Etodolac Sales and Growth Rate (2014-2019)
7.5 India Etodolac Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Etodolac Sales and Growth Rate (2014-2019)
8 South America Etodolac by Country
8.1 South America Etodolac Sales, Revenue and Market Share by Country
8.1.1 South America Etodolac Sales and Market Share by Country (2014-2019)
8.1.2 South America Etodolac Revenue and Market Share by Country (2014-2019)
8.2 Brazil Etodolac Sales and Growth Rate (2014-2019)
8.3 Argentina Etodolac Sales and Growth Rate (2014-2019)
8.4 Colombia Etodolac Sales and Growth Rate (2014-2019)
9 Middle East and Africa Etodolac by Countries
9.1 Middle East and Africa Etodolac Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Etodolac Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Etodolac Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Etodolac Sales and Growth Rate (2014-2019)
9.3 Turkey Etodolac Sales and Growth Rate (2014-2019)
9.4 Egypt Etodolac Sales and Growth Rate (2014-2019)
9.5 Nigeria Etodolac Sales and Growth Rate (2014-2019)
9.6 South Africa Etodolac Sales and Growth Rate (2014-2019)
10 Global Etodolac Market Segment by Type
10.1 Global Etodolac Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Etodolac Sales and Market Share by Type (2014-2019)
10.1.2 Global Etodolac Revenue and Market Share by Type (2014-2019)
10.2 Tablets Sales Growth and Price
10.2.1 Global Tablets Sales Growth (2014-2019)
10.2.2 Global Tablets Price (2014-2019)
10.3 Capsules Sales Growth and Price
10.3.1 Global Capsules Sales Growth (2014-2019)
10.3.2 Global Capsules Price (2014-2019)
11 Global Etodolac Market Segment by Application
11.1 Global Etodolac Sales Market Share by Application (2014-2019)
11.2 Rheumatoid Arthritis Sales Growth (2014-2019)
11.3 Osteoarthritis Sales Growth (2014-2019)
11.4 Mild to Moderate Pain Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Etodolac Market Forecast (2019-2024)
12.1 Global Etodolac Sales, Revenue and Growth Rate (2019-2024)
12.2 Etodolac Market Forecast by Regions (2019-2024)
12.2.1 North America Etodolac Market Forecast (2019-2024)
12.2.2 Europe Etodolac Market Forecast (2019-2024)
12.2.3 Asia-Pacific Etodolac Market Forecast (2019-2024)
12.2.4 South America Etodolac Market Forecast (2019-2024)
12.2.5 Middle East and Africa Etodolac Market Forecast (2019-2024)
12.3 Etodolac Market Forecast by Type (2019-2024)
12.3.1 Global Etodolac Sales Forecast by Type (2019-2024)
12.3.2 Global Etodolac Market Share Forecast by Type (2019-2024)
12.4 Etodolac Market Forecast by Application (2019-2024)
12.4.1 Global Etodolac Sales Forecast by Application (2019-2024)
12.4.2 Global Etodolac Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Etodolac Picture
Table Product Specifications of Etodolac
Figure Global Sales Market Share of Etodolac by Types in 2018
Table Etodolac Types for Major Manufacturers
Figure Tablets Picture
Figure Capsules Picture
Figure Etodolac Sales Market Share by Applications in 2018
Figure Rheumatoid Arthritis Picture
Figure Osteoarthritis Picture
Figure Mild to Moderate Pain Picture
Figure Other Picture
Figure United States Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure France Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure UK Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure China Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure India Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Etodolac Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Etodolac Revenue (Value) and Growth Rate (2014-2024)
Table Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Amneal Pharmaceuticals Etodolac Type and Applications
Table Amneal Pharmaceuticals Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Genpharm Ulc Basic Information, Manufacturing Base and Competitors
Table Genpharm Ulc Etodolac Type and Applications
Table Genpharm Ulc Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Physicians Total Care Basic Information, Manufacturing Base and Competitors
Table Physicians Total Care Etodolac Type and Applications
Table Physicians Total Care Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Actavis Elizabeth Basic Information, Manufacturing Base and Competitors
Table Actavis Elizabeth Etodolac Type and Applications
Table Actavis Elizabeth Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Blenheim Pharmacal Basic Information, Manufacturing Base and Competitors
Table Blenheim Pharmacal Etodolac Type and Applications
Table Blenheim Pharmacal Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Etodolac Type and Applications
Table Teva Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Taro Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Taro Pharmaceuticals Etodolac Type and Applications
Table Taro Pharmaceuticals Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Apotex Basic Information, Manufacturing Base and Competitors
Table Apotex Etodolac Type and Applications
Table Apotex Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table PD-Rx Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table PD-Rx Pharmaceuticals Etodolac Type and Applications
Table PD-Rx Pharmaceuticals Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Nucare Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Nucare Pharmaceuticals Etodolac Type and Applications
Table Nucare Pharmaceuticals Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Eon Labs Basic Information, Manufacturing Base and Competitors
Table Eon Labs Etodolac Type and Applications
Table Eon Labs Etodolac Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Etodolac Sales by Manufacturer (2017-2018)
Figure Global Etodolac Sales Market Share by Manufacturer in 2017
Figure Global Etodolac Sales Market Share by Manufacturer in 2018
Table Global Etodolac Revenue by Manufacturer (2017-2018)
Figure Global Etodolac Revenue Market Share by Manufacturer in 2017
Figure Global Etodolac Revenue Market Share by Manufacturer in 2018
Figure Top 3 Etodolac Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Etodolac Manufacturer (Revenue) Market Share in 2018
Figure Global Etodolac Sales and Growth Rate (2014-2019)
Figure Global Etodolac Revenue and Growth Rate (2014-2019)
Table Global Etodolac Sales by Regions (2014-2019)
Table Global Etodolac Sales Market Share by Regions (2014-2019)
Table Global Etodolac Revenue by Regions (2014-2019)
Figure Global Etodolac Revenue Market Share by Regions (2014-2019)
Figure Global Etodolac Revenue Market Share by Regions in 2018
Figure North America Etodolac Sales and Growth Rate (2014-2019)
Figure Europe Etodolac Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Etodolac Sales and Growth Rate (2014-2019)
Figure South America Etodolac Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Etodolac Sales and Growth Rate (2014-2019)
Figure North America Etodolac Revenue and Growth Rate (2014-2019)
Table North America Etodolac Sales by Countries (2014-2019)
Table North America Etodolac Sales Market Share by Countries (2014-2019)
Figure North America Etodolac Sales Market Share by Countries (2014-2019)
Figure North America Etodolac Sales Market Share by Countries in 2018
Table North America Etodolac Revenue by Countries (2014-2019)
Table North America Etodolac Revenue Market Share by Countries (2014-2019)
Figure North America Etodolac Revenue Market Share by Countries (2014-2019)
Figure North America Etodolac Revenue Market Share by Countries in 2018
Figure United States Etodolac Sales and Growth Rate (2014-2019)
Figure Canada Etodolac Sales and Growth Rate (2014-2019)
Figure Mexico Etodolac Sales and Growth Rate (2014-2019)
Figure Europe Etodolac Revenue and Growth Rate (2014-2019)
Table Europe Etodolac Sales by Countries (2014-2019)
Table Europe Etodolac Sales Market Share by Countries (2014-2019)
Table Europe Etodolac Revenue by Countries (2014-2019)
Figure Europe Etodolac Revenue Market Share by Countries (2014-2019)
Figure Europe Etodolac Revenue Market Share by Countries in 2018
Figure Germany Etodolac Sales and Growth Rate (2014-2019)
Figure UK Etodolac Sales and Growth Rate (2014-2019)
Figure France Etodolac Sales and Growth Rate (2014-2019)
Figure Russia Etodolac Sales and Growth Rate (2014-2019)
Figure Italy Etodolac Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Etodolac Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Etodolac Sales by Countries (2014-2019)
Table Asia-Pacific Etodolac Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Etodolac Sales Market Share by Countries 2018
Table Asia-Pacific Etodolac Revenue by Countries (2014-2019)
Figure Asia-Pacific Etodolac Revenue Market Share by Countries 2018
Figure China Etodolac Sales and Growth Rate (2014-2019)
Figure Japan Etodolac Sales and Growth Rate (2014-2019)
Figure Korea Etodolac Sales and Growth Rate (2014-2019)
Figure India Etodolac Sales and Growth Rate (2014-2019)
Figure Southeast Asia Etodolac Sales and Growth Rate (2014-2019)
Figure South America Etodolac Revenue and Growth Rate (2014-2019)
Table South America Etodolac Sales by Countries (2014-2019)
Table South America Etodolac Sales Market Share by Countries (2014-2019)
Figure South America Etodolac Sales Market Share by Countries in 2018
Table South America Etodolac Revenue by Countries (2014-2019)
Table South America Etodolac Revenue Market Share by Countries (2014-2019)
Figure South America Etodolac Revenue Market Share by Countries in 2018
Figure Brazil Etodolac Sales and Growth Rate (2014-2019)
Figure Argentina Etodolac Sales and Growth Rate (2014-2019)
Figure Colombia Etodolac Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Etodolac Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Etodolac Sales by Countries (2014-2019)
Table Middle East and Africa Etodolac Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Etodolac Sales Market Share by Countries in 2018
Table Middle East and Africa Etodolac Revenue by Countries (2014-2019)
Table Middle East and Africa Etodolac Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Etodolac Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Etodolac Revenue Market Share by Countries in 2018
Figure Saudi Arabia Etodolac Sales and Growth Rate (2014-2019)
Figure UAE Etodolac Sales and Growth Rate (2014-2019)
Figure Egypt Etodolac Sales and Growth Rate (2014-2019)
Figure Nigeria Etodolac Sales and Growth Rate (2014-2019)
Figure South Africa Etodolac Sales and Growth Rate (2014-2019)
Table Global Etodolac Sales by Type (2014-2019)
Table Global Etodolac Sales Share by Type (2014-2019)
Table Global Etodolac Revenue by Type (2014-2019)
Table Global Etodolac Revenue Share by Type (2014-2019)
Figure Global Tablets Sales Growth (2014-2019)
Figure Global Tablets Price (2014-2019)
Figure Global Capsules Sales Growth (2014-2019)
Figure Global Capsules Price (2014-2019)
Table Global Etodolac Sales by Application (2014-2019)
Table Global Etodolac Sales Share by Application (2014-2019)
Figure Global Osteoarthritis Sales Growth (2014-2019)
Figure Global Mild to Moderate Pain Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Etodolac Sales, Revenue and Growth Rate (2019-2024)
Table Global Etodolac Sales Forecast by Regions (2019-2024)
Table Global Etodolac Market Share Forecast by Regions (2019-2024)
Figure North America Sales Etodolac Market Forecast (2019-2024)
Figure Europe Sales Etodolac Market Forecast (2019-2024)
Figure Asia-Pacific Sales Etodolac Market Forecast (2019-2024)
Figure South America Sales Etodolac Market Forecast (2019-2024)
Figure Middle East and Africa Sales Etodolac Market Forecast (2019-2024)
Table Global Etodolac Sales Forecast by Type (2019-2024)
Table Global Etodolac Market Share Forecast by Type (2019-2024)
Table Global Etodolac Sales Forecast by Application (2019-2024)
Table Global Etodolac Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の軽度から中等度のアトピー性皮膚炎の治療市場：市場規模・現状・予測 Mild-to-moderate atopic dermatitis is a chronic inflammatory skin disease often confined to the flexural surfaces of the body and usually begins in childhood.Drug treatment can further be segmented into antihistamines, antibiotics, emollients, corticosteroids, and calcineurin inhibitors. North Ameri…- 軽中等度アトピー性皮膚炎治療市場：世界及び中国市場分析・予測（～2024年） Mild-to-Moderate Atopic Dermatitis Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Mild-to-Moderate Atopic Dermatitis Treatment industry with a focus on the Chinese market. The report provides key statistics on the m…
- 世界の慢性関節リウマチ（RA）薬市場：市場規模・現状・予測 Rheumatoid arthritis (RA) is an inflammatory disease that progresses over time affecting the joints. The symptoms aggravate over time, which is why medication for RA becomes essential to stop the inflammation. There is no permanent cure for rheumatoid arthritis, though increasing research activities…
- 世界の慢性関節リウマチの治療市場：市場規模・現状・予測 Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints.The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. In 2018, the global Rheumatoid Arthritis Treatment marke…
- 慢性関節リウマチ薬剤市場：世界及び中国市場分析・予測（～2024年） Drugs for Rheumatoid Arthritis Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Drugs for Rheumatoid Arthritis industry with a focus on the Chinese market. The report provides key statistics on the market status of the Drugs fo…